Description:
Gemcabene is an orally available lipid-lowering small molecule designed to target known lipid metabolic pathways, as an adjunctive therapy to reduce LDL-C, hsCRP and triglycerides (TGs). Currentl, Gemcabene is under Phase-II clinical trials in Hypertriglyceridaemia in USA.
- Molecular Weight: 302.41
- Molecular Formula: C16H30O5
Purity: >98%
Canonical SMILES:
CC(C)(CCCCOCCCCC(C)(C)C(=O)O)C(=O)O
InChI:
InChI=1S/C16H30O5/c1-15(2,13(17)18)9-5-7-11-21-12-8-6-10-16(3,4)14(19)20/h5-12H2,1-4H3,(H,17,18)(H,19,20)
InChIKey: SDMBRCRVFFHJKR-UHFFFAOYSA-N
Synonyms:
6-(5-carboxy-5-methyl-hexoxy)-2,2-dimethyl-hexanoic acid; gemcabene; 6,6'-oxybis(2,2-dimethylhexanoic acid); PD72953; PD 72953; PD-72953
More details are to be found on supplier website
